Vulvovaginal Candidiasis (VVC) – A Complete Patient Guide
Overview
Vulvovaginal candidiasis (VVC), commonly known as a yeast infection, is an over‑growth of the fungus Candida (most often Candida albicans) in the vagina and surrounding vulvar tissue. It is one of the most frequent causes of vaginitis worldwide.
- Who it affects: Women of any age, but the highest incidence is seen in women of reproductive age (15‑45 years).
- Prevalence: Approximately 70–75 % of women will experience at least one episode of VVC in their lifetime; about 40–50 % have recurrent episodes (≥4 per year).[1][2]
- Global burden: The CDC estimates that yeast infections account for 10–15 % of all gynecologic visits in the United States each year.[3]
Symptoms
Symptoms can range from mild irritation to severe discomfort. Not all women experience every sign.
- Itching (pruritus): Often described as intense and persistent, most common symptom.
- Burning sensation: May be felt during urination or sexual intercourse.
- Vaginal discharge: Thick, white, “cottage‑cheese” consistency; usually odorless.
- Redness and swelling: Involving the vulva, labia minora, and sometimes the introitus.
- Dyspareunia: Pain or discomfort during intercourse.
- Soreness or irritation: May extend to the perineum and inner thighs.
- Fissures or cracks: In severe cases, especially after vigorous scratching.
- Fever or chills: Rare, but a sign of a secondary bacterial infection.
Causes and Risk Factors
Primary cause
VVC results when the natural balance of vaginal flora is disrupted, allowing Candida to proliferate. Under normal conditions, lactobacilli produce lactic acid that keeps the vaginal pH acidic (≈ 3.8–4.5) and suppresses fungal growth.
Common risk factors
- Antibiotic use: Broad‑spectrum antibiotics (e.g., tetracyclines, fluoroquinolones) reduce lactobacilli, increasing fungal overgrowth.[4]
- Hormonal changes: Pregnancy, oral contraceptives, and hormone replacement therapy raise estrogen levels, which enhance glycogen in vaginal epithelium—fuel for Candida.[5]
- High blood sugar: Diabetes mellitus (especially uncontrolled) provides excess glucose for fungal growth.[6]
- Immunosuppression: HIV infection, corticosteroid therapy, chemotherapy, or biologic agents.
- Moist environments: Tight, non‑breathable clothing, prolonged wetness from swimsuits or sweaty workouts.
- Douching & scented products: Disrupt normal flora and pH.
- Sexual activity: While not classified as an STI, transmission between partners can occur; friction may exacerbate symptoms.
- Previous episodes: A history of VVC is the strongest predictor of recurrence.
Diagnosis
Accurate diagnosis distinguishes VVC from bacterial vaginosis, trichomoniasis, and non‑infectious causes of vulvovaginal irritation.
Clinical evaluation
- History: Frequency of episodes, recent antibiotics, hormone use, diabetes control.
- Physical exam: Visual inspection for erythema, discharge, and lesions.
Laboratory tests
- Microscopy (wet mount): A saline or potassium hydroxide (KOH) preparation of vaginal discharge reveals budding yeast and pseudohyphae within minutes.[7]
- Culture: Sabouraud agar culture confirms species and antimicrobial susceptibility; useful in recurrent or refractory cases.
- pH measurement: Vaginal pH >4.5 suggests bacterial vaginosis or trichomoniasis; VVC typically maintains a normal acidic pH.
- PCR/NAAT: Rapid nucleic‑acid amplification tests are increasingly available and provide species‑level identification.
Treatment Options
Antifungal medications
Most cases resolve with short‑course topical or oral agents.
| Medication | Form | Typical Regimen | Notes |
|---|---|---|---|
| Fluconazole | Oral tablet | 150 mg single dose; repeat after 72 h for severe cases | First‑line for uncomplicated VVC; safe in pregnancy (category C) |
| Clotrimazole | Topical cream/ovule | 100 mg intravaginally for 7 days | Effective for mild‑moderate infection |
| Miconazole | Topical cream/gel | 200 mg intravaginally for 7 days or 3‑day regimen | Can be used in pregnancy |
| Tioconazole | Single‑dose intravaginal | 5 % cream, one dose | Convenient for those who dislike daily dosing |
| Boric acid suppositories | Vaginal capsule (600 mg) | Every night for 14 days (used for refractory cases) | Not for pregnant women; toxic if ingested |
Recurrent VVC (≥4 episodes/yr)
- Induction phase: Fluconazole 150 mg every 72 h for 3 doses, then weekly for 6 months.
- Maintenance phase: Fluconazole 150 mg once weekly for 6 months – 1 year, or topical azole nightly for a month, then twice weekly.
- Address underlying risk factors (e.g., tighten glycemic control, discontinue unnecessary antibiotics).
Lifestyle and adjunct measures
- Wear cotton underwear and loose‑fitting clothing.
- Avoid scented soaps, douches, and spermicidal products.
- Change out of wet swimwear promptly.
- Maintain good glycemic control if diabetic.
Living with Vulvovaginal Candidiasis
Even after successful treatment, women may experience anxiety about recurrence or lingering discomfort.
Daily management tips
- Hygiene: Gently wash the vulva with warm water; avoid harsh scrubbing.
- Clothing: Opt for breathable fabrics; replace panty liners daily.
- Sexual health: Use water‑based lubricants to reduce friction; discuss prophylactic treatment with a partner if recurrent.
- Dietary considerations: While evidence is mixed, some women find reduced sugar and refined carbs lessen episodes.
- Stress management: Chronic stress can alter immune function; regular exercise, mindfulness, and adequate sleep are beneficial.
When to follow‑up
If symptoms persist beyond 72 hours after initiating therapy or recur within a month, schedule a follow‑up appointment for repeat testing and possible culture‑guided treatment.
Prevention
- Judicious antibiotic use: Ask your clinician whether an antibiotic is truly needed.
- Probiotic support: Daily oral probiotic containing Lactobacillus rhamnosus GR‑1 or L. reuteri RC‑14 may help maintain vaginal flora; evidence is supportive but not definitive.[8]
- Glycemic control: Keep HbA1c < 7 % if you have diabetes.
- Safe sexual practices: Use condoms, avoid spermicidal lubricants, and consider partner treatment if both experience symptoms.
- Clothing & hygiene: Change out of wet clothing quickly, avoid prolonged use of tight leggings or synthetic underwear.
- Regular gynecologic care: Annual examinations help catch asymptomatic infections early.
Complications
When left untreated, VVC can lead to:
- Secondary bacterial infection: Breaks in the skin may become colonized with Staphylococcus or Streptococcus species.
- Chronic vulvar pain (vulvodynia): Persistent neuropathic pain after infection clears.
- Pregnancy concerns: While uncomplicated VVC rarely harms the fetus, severe infection can increase the risk of preterm labor.
- Impact on quality of life: Recurrent episodes are linked to anxiety, sexual dysfunction, and decreased work productivity.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- High fever (≥38.5 °C / 101.3 °F) with chills.
- Severe pelvic or abdominal pain that comes on suddenly.
- Rapid swelling, redness, or a foul‑smelling discharge suggesting a serious secondary bacterial infection (e.g., necrotizing fasciitis).
- Difficulty urinating or a sudden inability to pass urine.
- Signs of an allergic reaction to medication (hives, swelling of the face or throat, trouble breathing).
These symptoms may indicate a complication that requires prompt medical attention.
References
- Mayo Clinic. “Vulvovaginal yeast infection.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/yeast-infection
- World Health Organization. “Global prevalence of vulvovaginal candidiasis.” 2022. https://www.who.int/publications/i/item/9789240016596
- CDC. “Vulvovaginal Candidiasis – Facts and Statistics.” 2021. https://www.cdc.gov/fungal/diseases/candidiasis/index.html
- Johns Hopkins Antibiotic Guide. “Impact of antibiotics on vaginal flora.” 2020.
- NIH. “Hormonal influences on vaginal microbiome.” 2021. PMCID: PMC7894123
- American Diabetes Association. “Diabetes and susceptibility to infections.” 2022.
- Clinical Microbiology Reviews. “Laboratory diagnosis of vulvovaginal candidiasis.” 2020;33(2):e00123.
- Journal of Women’s Health. “Probiotic Lactobacillus for prevention of recurrent VVC.” 2023;32(4):456‑463.